Drug therapy in hospitalized patients with very severe symptoms following COVID-19
Guardado en:
Autores principales: | Rohollah Valizadeh, Nahid Dadashzadeh, Roya Zakeri, Steven James Kellner, Mohsen Mohammad Rahimi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Society of Diabetic Nephropathy Prevention
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/45103307d48b454fae0bc793397cc19b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Molecular Structure and Case Fatality Rate of COVID-19
por: Zahra Sadat Aghamir, et al.
Publicado: (2020) -
Efficacy and safety of arbidol (umifenovir) in patients with COVID‐19: A systematic review and meta‐analysis
por: Behnam Amani, et al.
Publicado: (2021) -
Vaccine Production by Recognizing the Functional Mechanisms of COVID-19
por: Akram Mirzaei, et al.
Publicado: (2020) -
Fulminant corporal infection induced by Fournier gangrene: A case report with unusual presentation
por: Sultan S. Almaiman, et al.
Publicado: (2022) -
A Review of Animal Laboratory Practice in the COVID-19 and Safety Concerns
por: Rahil Mashhadi, et al.
Publicado: (2020)